LYTIR

Company · DMRA

Damora Therapeutics, Inc.

Nasdaq's symbol directory lists DMRA on Nasdaq as “Damora Therapeutics, Inc. - Ordinary Shares”.

In the 12 months to Nov 8, 2026: insiders bought on 1 occasion ($253K); insiders sold on 1 occasion ($7K).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $253K in total; Insider sales: $7K in total.Jul: Insider sales $7KSep: Insider purchases $253KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $253KInsider sales below: $7K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Jarrett Jennifer, Director, President and CEO bought on 1 day latest Sep 25, 2026 bought $253K
  2. Winslow Garrett, General Counsel sold on 1 day latest Jul 6, 2026 sold $7K
Every trade (2)
  1. BUYJarrett Jennifer, Director, President and CEO bought Sep 25, 2026 12,500 shares filing $253K
  2. SELLWinslow Garrett, General Counsel sold Jul 6, 2026 245 shares filing $7K

Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.